Join the club for FREE to access the whole archive and other member benefits.


Pharmaceutical research and development.

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.

Visit website:





AbbVie News

CollPlant gains $10m milestone from AbbVie to develop dermal and soft tissue filler

Longevity Technology - 04-Jul-2023

Recombinant human collagen based fillers help advance the field regenerative aesthetics


AbbVie and Calico extends their collab up to 2025 with a $1 billion deal

FierceBiotech - 27-Jul-2021

Supports ageing research and advancing early-stage projects to phase 2 trials over the next decade


Calico and AbbVie announced early-stage trials for new therapies

Calico - 03-Feb-2021

Clinical trials in progress for potential targets of cancer and neurodegenerative diseases


Calico partners with AbbVie to develop a cancer drug

San Francisco Business Times - 19-Oct-2020

Ex-Genentech CEO's drug company starts first clinical trial of cancer research


Silicon Valley and rich people invest to slow down ageing and live longer

This Is Money - 17-Mar-2018

All the money in the world to fight ageing and death


Doctors promoting treatments on social media fail to disclose ties to drug makers

STAT - 29-Feb-2016

US physicians often fail to mention that they have accepted thousands of dollars from the compani...